1231040
1231048
1231051
1231049
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical Research
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
IDM Capacity Building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
Cell Imaging Microscope
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.

University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice

Home > Home

News

Monday, 27 January 2020
Sequencing the future

The African genome is the oldest, and as such, the most diverse in the world. But Africans have largely been under-represented in neurogenetic studies. The University of Cape Town (UCT) Neuroscience Institute is helping to change that through a range of forward-looking, international, collaborative projects on genetics and the nervous system.

Publication Date:
Fri, 24 Jan 2020 - 10:15
Community-based intervention to identify undiagnosed TB cases

In a move set to revolutionise tuberculosis (TB) diagnosis and treatment by enabling early detection of infectious cases, molecular diagnostics – the technique used to diagnose and monitor a disease – will be taken out of the laboratory and into the community.

Publication Date:
Tue, 21 Jan 2020 - 08:30
Cancer treatment gets personal

The search for better cancer treatments continues, as current options often cause severe side effects. Less than 5% of experimental anticancer drugs are approved for use in humans, but scientists are bringing new technologies to the quest.

Publication Date:
Wed, 15 Jan 2020 - 13:45
IDM Soccer Tournament

It was a full year at the Institute of Infectious Disease and Molecular Medicine (IDM) in 2019. The latter part of the calendar included a visit from the International Scientific Advisory Committee, a successful Postgraduate Student Publication Award Ceremony, the Desmond Tutu HIV Foundation and the Wellcome Centre for Infectious Diseases in Africa hosting a World Aids Day exhibition-cum-Coffee Club. And as if that wasn’t enough – the Wolfson Pavilion was being renovated.

Publication Date:
Wed, 08 Jan 2020 - 09:00

Pages

TOP